PHM de Mulder

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours

Cora N. Sternberg, PHM de Mulder, Jan H. Schornagel et al. · European Journal of Cancer · 2005 · 542 citations

Year Update, Urology, Surgical Oncology +5

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients

Ivar Bleumer, Alexander Knuth, Egbert Oosterwijk et al. · British Journal of Cancer · 2004 · 173 citations · Full text

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Peter Palmer, J. Vinke, Thierry Philip et al. · Annals of Oncology · 1992 · 156 citations · Full text

Prognostic Factors, Urology, Genitourinary Cancer +7

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jan B. Vermorken, M. Clavel et al. · Annals of Oncology · 1994 · 135 citations

Medicine, Ly 188011, Phase Ii Study +8

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group

R. de Wit, G. Stoter, Dirk Th. Sleijfer et al. · British Journal of Cancer · 1995 · 99 citations

Urology, Surgical Oncology, Genitourinary Cancer +8